EP2320917A4 - Methods of preventing, arresting or reversing tumourigenesis and of identifying compounds capable of the same - Google Patents

Methods of preventing, arresting or reversing tumourigenesis and of identifying compounds capable of the same

Info

Publication number
EP2320917A4
EP2320917A4 EP09803219A EP09803219A EP2320917A4 EP 2320917 A4 EP2320917 A4 EP 2320917A4 EP 09803219 A EP09803219 A EP 09803219A EP 09803219 A EP09803219 A EP 09803219A EP 2320917 A4 EP2320917 A4 EP 2320917A4
Authority
EP
European Patent Office
Prior art keywords
arresting
preventing
methods
same
compounds capable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09803219A
Other languages
German (de)
French (fr)
Other versions
EP2320917A1 (en
Inventor
Yoshiaki Ito
Kosei Ito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agency for Science Technology and Research Singapore
Original Assignee
Agency for Science Technology and Research Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency for Science Technology and Research Singapore filed Critical Agency for Science Technology and Research Singapore
Publication of EP2320917A1 publication Critical patent/EP2320917A1/en
Publication of EP2320917A4 publication Critical patent/EP2320917A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
EP09803219A 2008-07-29 2009-07-29 Methods of preventing, arresting or reversing tumourigenesis and of identifying compounds capable of the same Withdrawn EP2320917A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8448608P 2008-07-29 2008-07-29
PCT/SG2009/000268 WO2010014043A1 (en) 2008-07-29 2009-07-29 Methods of preventing, arresting or reversing tumourigenesis and of identifying compounds capable of the same

Publications (2)

Publication Number Publication Date
EP2320917A1 EP2320917A1 (en) 2011-05-18
EP2320917A4 true EP2320917A4 (en) 2011-11-09

Family

ID=41610589

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09803219A Withdrawn EP2320917A4 (en) 2008-07-29 2009-07-29 Methods of preventing, arresting or reversing tumourigenesis and of identifying compounds capable of the same

Country Status (2)

Country Link
EP (1) EP2320917A4 (en)
WO (1) WO2010014043A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4040156A1 (en) * 2014-01-28 2022-08-10 Quest Diagnostics Investments Incorporated Method for detecting an adenoma-adenocarcinoma transition in cancer

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002061069A1 (en) * 2001-01-29 2002-08-08 Suk-Chul Bae Runx3 gene showing anti-tumor activity and use thereof
WO2006057623A1 (en) * 2004-11-29 2006-06-01 National University Of Singapore Runx3 antibodies and method of obtaining the antibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070237770A1 (en) * 2001-11-30 2007-10-11 Albert Lai Novel compositions and methods in cancer
US7611847B2 (en) * 2005-06-01 2009-11-03 Agency For Science, Technology And Research Method for identifying an intestinal phenotype
US7507536B2 (en) * 2005-10-07 2009-03-24 The Johns Hopkins University Methylation markers for diagnosis and treatment of ovarian cancer
WO2008070082A2 (en) * 2006-12-04 2008-06-12 The Johns Hopkins University Stem-progenitor cell specific micro-ribonucleic acids and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002061069A1 (en) * 2001-01-29 2002-08-08 Suk-Chul Bae Runx3 gene showing anti-tumor activity and use thereof
WO2006057623A1 (en) * 2004-11-29 2006-06-01 National University Of Singapore Runx3 antibodies and method of obtaining the antibodies

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KATOH MASARU: "Dysregulation of stem cell signaling network due to germline mutation, SNP, Helicobacter pylori infection, epigenetic change and genetic alteration in gastric cancer.", CANCER BIOLOGY & THERAPY JUN 2007 LNKD- PUBMED:17568183, vol. 6, no. 6, June 2007 (2007-06-01), pages 832 - 839, XP002658187, ISSN: 1555-8576 *
See also references of WO2010014043A1 *
WETERING VAN DE M ET AL: "The ss-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells", CELL, CELL PRESS, US, vol. 111, 18 October 2002 (2002-10-18), pages 241 - 250, XP002324236, ISSN: 0092-8674, DOI: 10.1016/S0092-8674(02)01014-0 *

Also Published As

Publication number Publication date
WO2010014043A1 (en) 2010-02-04
EP2320917A1 (en) 2011-05-18

Similar Documents

Publication Publication Date Title
NL301192I2 (en) Finerenone and its salts, solvates and solvates of the salts thereof
IL269858A (en) Pyridone and aza-pyridone compounds, pharmaceutical composition and kits comprising the same and uses thereof
IL254218A0 (en) Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
EP2153838A4 (en) Anti-norovirus agent, and composition comprising the same
EP2247165A4 (en) Lighting device, and display device having the same
IL206127A0 (en) Azolylmethyloxiranes, use thereof and agents containing the same
EP2374912A4 (en) Antibacterial coating, its preparation methods and metalwork containing the coating
EP2253227A4 (en) Saltiness-strengthening agent and food or drink containing the same
IL211131A0 (en) Inhbb epitope and vaccines containing the same
HK1130489A1 (en) Substituted-quinoxaline-type-piperidine compounds and the uses thereof
PL2354161T3 (en) Anti-nr10 antibody, and use thereof
EP2652506A4 (en) The use anti-cxcl16 and anti-cxcr6 antibodies for the treatment or detecting cancer
HK1131140A1 (en) Substituted prolinamides, and the use thereof
EP2287155A4 (en) Acylthiourea compound or salt thereof, and use of the compound or the salt
IL221906B (en) Pde10 inhibitor compounds, compositions comprising the same and uses thereof
IL213043A0 (en) Lantibiotic carboxyamide derivatives, compositions comprising the same and uses thereof
EP2307052A4 (en) Anti-beta-2-microglobulin agents and the use thereof
EP2351732A4 (en) Novel compound ramalin, and use thereof
EP2457092A4 (en) Cancer biomarker and the use thereof
IL207639A0 (en) Pyrrolopyrimidinecarboxamide compounds, compositions comprising the same and uses thereof
SI2354161T1 (en) Anti-nr10 antibody, and use thereof
IL208168A0 (en) Tetrahydroisoquinoline derivatives, compositions comprising the same and use thereof
HRP20160578T1 (en) Substituted furancarboxamides, and use thereof
EP2192122A4 (en) Dithiolopyrrolone compounds, the preparation and the use thereof
EP2320917A4 (en) Methods of preventing, arresting or reversing tumourigenesis and of identifying compounds capable of the same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110211

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

AX Request for extension of the european patent

Extension state: AL BA RS

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/574 20060101ALI20110908BHEP

Ipc: C12Q 1/00 20060101ALI20110908BHEP

Ipc: A61K 35/00 20060101AFI20110908BHEP

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20111012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120201